Study Of Third Trimester Fetomaternal Outcome in Rh-Negative Patients
International Journal of Drug Delivery Technology · 05.06.2026 · 16 (49s)
DOI: 10.25258/ijddt.16.49s.35 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 05.06.2026. Verfasst von Vivek Patel und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The adverse pregnancy outcome caused by rh isoimmunization is still preventable, especially for Rh-negative women carrying Rh-positive fetuses. The study has evaluated the Foetal and Maternal outcome of Rh-negative women admitted at Dhiraj General Hospital in third trimester of pregnancy. Over 18 months, a sample of 47–50 women were analyzed according to the maternal age, parity, gestational age, blood group distribution, prophylaxis status, pregnancy outcomes. Most of the participants were in their 18-24 age group and primiparous, and O negative blood group was the highest blood group of the participants. Anti-D prophylaxis was given to 70% at 28 weeks gestation and 90% post delivery. C section births were performed for fetal distress or for maternal health issues, and vaginal delivery was the predominant choice. The neonatal outcome was good with 93.88% having APGAR score ≥7 at 1 minute and 100% at 5 minutes. The overall 98% survival rate included 32.65% who needed NICU treatment, mainly for jaundice and respiratory distress. Observed but not significantly associated with prophylaxis were maternal complications like postpartum haemorrhage and anemia. The researchers' findings suggest that anti-D can significantly decrease neonatal complications, without affecting maternal health. Greater implementation of antenatal care, better awareness and universal prophylaxis are essential for continuing to decrease Rh isoimmunization and improve foetal and maternal outcomes.
Zitieren
APA
Patel, V., Chandrayan, P., & Atodaria, A. (2026). Study Of Third Trimester Fetomaternal Outcome in Rh-Negative Patients. International Journal of Drug Delivery Technology, 16(49s). https://doi.org/10.25258/ijddt.16.49s.35
Vancouver
Patel V, Chandrayan P, Atodaria A. Study Of Third Trimester Fetomaternal Outcome in Rh-Negative Patients. International Journal of Drug Delivery Technology. 2026;16(49s). doi:10.25258/ijddt.16.49s.35
BibTeX
@article{Patel2026,
author = {Patel, Vivek and Chandrayan, Piyusha and Atodaria, Aditi},
title = {Study Of Third Trimester Fetomaternal Outcome in Rh-Negative Patients},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {49s},
doi = {10.25258/ijddt.16.49s.35}
}
EUVIMED